Glenmede Trust’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,993
| Closed | -$1.19K | – | 3263 |
|
|
2018
Q4 | $1.19K | Buy |
8,993
+37
| +0.4% | +$4.74K | 0.01% | 696 |
|
|
2018
Q3 | $1.2M | Hold |
8,956
| – | – | ﹤0.01% | 713 |
|
|
2018
Q2 | $1.43M | Buy |
8,956
+3,753
| +72% | +$557K | 0.01% | 651 |
|
|
2018
Q1 | $691K | Hold |
5,203
| – | – | ﹤0.01% | 858 |
|
|
2017
Q4 | $691K | Sell |
5,203
-2,400
| -32% | -$307K | ﹤0.01% | 858 |
|
|
2017
Q3 | $945K | Sell |
7,603
-4,755
| -38% | -$655K | ﹤0.01% | 774 |
|
|
2017
Q2 | $1.39M | Hold |
12,358
| – | – | 0.01% | 707 |
|
|
2017
Q1 | $1.39M | Buy |
12,358
+8,000
| +184% | +$932K | 0.01% | 707 |
|
|
2016
Q4 | $458K | Sell |
4,358
-2,347
| -35% | -$252K | ﹤0.01% | 958 |
|
|
2016
Q3 | $845K | Sell |
6,705
-860
| -11% | -$109K | ﹤0.01% | 786 |
|
|
2016
Q2 | $1.04M | Buy |
7,565
+1,312
| +21% | +$174K | 0.01% | 738 |
|
|
2016
Q1 | $867K | Buy |
6,253
+2,492
| +66% | +$342K | 0.01% | 774 |
|
|
2015
Q4 | $605K | Buy |
+3,761
| New | +$581K | ﹤0.01% | 863 |
|
|
2014
Q4 | – | Sell |
-100
| Closed | -$13K | – | 2654 |
|
|
2014
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 2081 |
|
|
2014
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 2016 |
|
|
2014
Q1 | $16K | Hold |
100
| – | – | ﹤0.01% | 1938 |
|
|
2013
Q4 | $13K | Hold |
100
| – | – | ﹤0.01% | 1935 |
|
|
2013
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 1935 |
|
|
2013
Q2 | $8K | Buy |
+100
| New | +$8.95K | ﹤0.01% | 1915 |
|
Glenmede Trust's ATHN Position: Q1 2019 in Review
Glenmede Trust sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 8,993 shares — an estimated $1.19K sold.
Glenmede Trust first reported a position in ATHN in Q2 2013 and held it in 19 quarters. The position peaked at $1.43M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Glenmede Trust reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Glenmede Trust sold 8,993 Athenahealth, Inc. shares in Q1 2019, an estimated $1.19K.
- Glenmede Trust first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 19 quarters.
- Glenmede Trust's Athenahealth, Inc. position peaked at $1.43M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Glenmede Trust's 13F filing for Q1 2019, filed 14 May 2019.